These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32961896)

  • 1. Therapeutic Benefit of the Association of Lodenafil with Mesenchymal Stem Cells on Hypoxia-induced Pulmonary Hypertension in Rats.
    Silva MMCD; Alencar AKN; Silva JSD; Montagnoli TL; Silva GFD; Rocha BS; Montes GC; Mendez-Otero R; Pimentel-Coelho PM; Vasques JF; Trahez MM; Sudo RT; Zapata-Sudo G
    Cells; 2020 Sep; 9(9):. PubMed ID: 32961896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The soluble guanylate cyclase stimulator riociguat ameliorates pulmonary hypertension induced by hypoxia and SU5416 in rats.
    Lang M; Kojonazarov B; Tian X; Kalymbetov A; Weissmann N; Grimminger F; Kretschmer A; Stasch JP; Seeger W; Ghofrani HA; Schermuly RT
    PLoS One; 2012; 7(8):e43433. PubMed ID: 22912874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of mesenchymal stem cell delivery via a novel cardiac bioscaffold on right ventricles of pulmonary arterial hypertensive rats.
    Schmuck EG; Hacker TA; Schreier DA; Chesler NC; Wang Z
    Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1005-H1013. PubMed ID: 30822119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of right coronary vascular dysfunction in severe pulmonary hypertensive rats using synchrotron radiation microangiography.
    Inagaki T; Pearson JT; Tsuchimochi H; Schwenke DO; Saito S; Higuchi T; Masaki T; Umetani K; Shirai M; Nakaoka Y
    Am J Physiol Heart Circ Physiol; 2021 Mar; 320(3):H1021-H1036. PubMed ID: 33481696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Right ventricular cyclic nucleotide signaling is decreased in hyperoxia-induced pulmonary hypertension in neonatal mice.
    Heilman RP; Lagoski MB; Lee KJ; Taylor JM; Kim GA; Berkelhamer SK; Steinhorn RH; Farrow KN
    Am J Physiol Heart Circ Physiol; 2015 Jun; 308(12):H1575-82. PubMed ID: 25862831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological Inhibition of mTOR Kinase Reverses Right Ventricle Remodeling and Improves Right Ventricle Structure and Function in Rats.
    Pena A; Kobir A; Goncharov D; Goda A; Kudryashova TV; Ray A; Vanderpool R; Baust J; Chang B; Mora AL; Gorcsan J; Goncharova EA
    Am J Respir Cell Mol Biol; 2017 Nov; 57(5):615-625. PubMed ID: 28679058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fischer rats exhibit maladaptive structural and molecular right ventricular remodelling in severe pulmonary hypertension: a genetically prone model for right heart failure.
    Suen CM; Chaudhary KR; Deng Y; Jiang B; Stewart DJ
    Cardiovasc Res; 2019 Mar; 115(4):788-799. PubMed ID: 30357319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sildenafil preserves lung endothelial function and prevents pulmonary vascular remodeling in a rat model of diastolic heart failure.
    Yin J; Kukucka M; Hoffmann J; Sterner-Kock A; Burhenne J; Haefeli WE; Kuppe H; Kuebler WM
    Circ Heart Fail; 2011 Mar; 4(2):198-206. PubMed ID: 21216837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural reversal of pulmonary vascular remodeling and right ventricular remodeling in SU5416/hypoxia-treated Sprague-Dawley rats.
    Zungu-Edmondson M; Shults NV; Melnyk O; Suzuki YJ
    PLoS One; 2017; 12(8):e0182551. PubMed ID: 28809956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension.
    Umar S; de Visser YP; Steendijk P; Schutte CI; Laghmani el H; Wagenaar GT; Bax WH; Mantikou E; Pijnappels DA; Atsma DE; Schalij MJ; van der Wall EE; van der Laarse A
    Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1606-16. PubMed ID: 19783775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
    Cheng G; Wang X; Li Y; He L
    Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased MAO-A Activity Promotes Progression of Pulmonary Arterial Hypertension.
    Sun XQ; Peters EL; Schalij I; Axelsen JB; Andersen S; Kurakula K; Gomez-Puerto MC; Szulcek R; Pan X; da Silva Goncalves Bos D; Schiepers REJ; Andersen A; Goumans MJ; Vonk Noordegraaf A; van der Laarse WJ; de Man FS; Bogaard HJ
    Am J Respir Cell Mol Biol; 2021 Mar; 64(3):331-343. PubMed ID: 33264068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct and indirect protection of right ventricular function by estrogen in an experimental model of pulmonary arterial hypertension.
    Liu A; Schreier D; Tian L; Eickhoff JC; Wang Z; Hacker TA; Chesler NC
    Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H273-83. PubMed ID: 24906919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synergistic therapeutic effect of hepatocyte growth factor and granulocyte colony-stimulating factor on pulmonary hypertension in rats.
    Guo Y; Su L; Li Y; Guo N; Xie L; Zhang D; Zhang X; Li H; Zhang G; Wang Y; Liu C
    Heart Vessels; 2014 Jul; 29(4):520-31. PubMed ID: 23933910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal effects of low-dose imatinib compared with sunitinib on monocrotaline-induced pulmonary and right ventricular remodeling in rats.
    Leong ZP; Okida A; Higuchi M; Yamano Y; Hikasa Y
    Vascul Pharmacol; 2018 Jan; 100():41-50. PubMed ID: 29100963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unraveling the Impact of miR-146a in Pulmonary Arterial Hypertension Pathophysiology and Right Ventricular Function.
    Santos-Gomes J; Mendes-Ferreira P; Adão R; Maia-Rocha C; Rego B; Poels M; Saint-Martin Willer A; Masson B; Provencher S; Bonnet S; Montani D; Perros F; Antigny F; Leite-Moreira AF; Brás-Silva C
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertension.
    Adão R; Mendes-Ferreira P; Santos-Ribeiro D; Maia-Rocha C; Pimentel LD; Monteiro-Pinto C; Mulvaney EP; Reid HM; Kinsella BT; Potus F; Breuils-Bonnet S; Rademaker MT; Provencher S; Bonnet S; Leite-Moreira AF; Brás-Silva C
    Cardiovasc Res; 2018 Jul; 114(8):1165-1177. PubMed ID: 29584808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosuvastatin, sildenafil and their combination in monocrotaline-induced pulmonary hypertension in rat.
    Jasińska-Stroschein M; Owczarek J; Wesołowska A; Orszulak-Michalak D
    Acta Pharm; 2014 Sep; 64(3):345-53. PubMed ID: 25296680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling.
    Schäfer S; Ellinghaus P; Janssen W; Kramer F; Lustig K; Milting H; Kast R; Klein M
    Cardiovasc Res; 2009 Apr; 82(1):30-9. PubMed ID: 19131365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex-dependent remodeling of right ventricular function in a rat model of pulmonary arterial hypertension.
    Kwan ED; Hardie BA; Garcia KM; Mu H; Wang TM; Valdez-Jasso D
    Am J Physiol Heart Circ Physiol; 2024 Aug; 327(2):H351-H363. PubMed ID: 38847755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.